Selective Progesterone Receptor Modulator Development and Use in the Treatment of Leiomyomata and Endometriosis
The DOI matches its Crossref record; 122 of the 127 references it cites were found in a registry or an index.
Abstract
Selective progesterone receptor modulators (SPRMs) represent a new class of progesterone receptor ligands. SPRMs exert clinically relevant tissue-selective progesterone agonist, antagonist, or mixed agonist/antagonist effects on various progesterone target tissues in vivo. Asoprisnil (J867) is the first SPRM to reach an advanced stage of clinical development for the treatment of symptomatic uterine fibroids and endometriosis. Asoprisnil belongs to the class of 11beta-benzaldoxime-substituted estratrienes that exhibit partial progesterone agonist/antagonist effects with high progesterone receptor specificity in animals and humans. Asoprisnil has no antiglucocorticoid activity in humans at therapeutic doses. It exhibits endometrial antiproliferative effects on the endometrium and breast in primates. Unlike progesterone antagonists, asoprisnil does not induce labor in relevant models of pregnancy and parturition. It induces amenorrhea primarily by targeting the endometrium. In human subjects with uterine fibroids, asoprisnil suppressed both the duration and intensity of uterine bleeding in a dose-dependent manner and reduced tumor volume in the absence of estrogen deprivation. In subjects with endometriosis, asoprisnil was effective in reducing nonmenstrual pain and dysmenorrhea. Asoprisnil may, therefore, provide a novel, tissue-selective approach to control endometriosis-related pain. SPRMs have the potential to become a novel treatment of uterine fibroids and endometriosis.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Therefore, a potential good efficacy of SPRMs on endometriosis was suggested [260–262], but no SPRMs are used in clinical practice.”
From Hormonal treatments for endometriosis: The endocrine background (2022) · cites this paper as [260]
Citations
Cites
Writing Group for the Women's Health Initiative Investigators (2002) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.288.3.321 · Cited by 15,889
The Steroid and Thyroid Hormone Receptor Superfamily
Evans, R. M. (1988) · Science · doi:10.1126/science.3283939 · Cited by 7,439
Giudice, L. C., & Kao, L. C. (2004) · The Lancet · doi:10.1016/s0140-6736(04)17403-5 · Cited by 3,166
Breast cancer and hormone-replacement therapy in the Million Women Study
(2003) · The Lancet · doi:10.1016/s0140-6736(03)14065-2 · Cited by 2,993
MOLECULAR MECHANISMS OF ACTION OF STEROID/THYROID RECEPTOR SUPERFAMILY MEMBERS
Tsai, M.-J., & O'Malley, B. W. (1994) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.63.070194.002315 · Cited by 2,932
High cumulative incidence of uterine leiomyoma in black and white women: Ultrasound evidence
Day Baird, D., Dunson, D. B., Hill, M. C., Cousins, D., & Schectman, J. M. (2003) · American Journal of Obstetrics and Gynecology · doi:10.1067/mob.2003.99 · Cited by 2,435
Sequence and Characterization of a Coactivator for the Steroid Hormone Receptor Superfamily
Oñate, S. A., Tsai, S. Y., Tsai, M.-J., & O'Malley, B. W. (1995) · Science · doi:10.1126/science.270.5240.1354 · Cited by 2,387
Steroid Receptor Interactions with Heat Shock Protein and Immunophilin Chaperones*
Pratt, W. B., & Toft, D. O. (1997) · Endocrine Reviews · doi:10.1210/edrv.18.3.0303 · Cited by 1,791
A transcriptional co-repressor that interacts with nuclear hormone receptors
Chen, J. D., & Evans, R. M. (1995) · Nature · doi:10.1038/377454a0 · Cited by 1,763
Breast cancer and hormone-replacement therapy: the Million Women Study
Beral, V., Banks, E., Reeves, G., & Bull, D. (2003) · The Lancet · doi:10.1016/s0140-6736(03)14596-5 · Cited by 1,273
Research works printed but not linked: 4
- Giangrande, Recent Prog Horm Res, 54, 291
- Brenner, 2005, Asoprisnil suppresses endometrial proliferation in cynomolgus macaques., J Soc Gynecol Invest, 12, 208A
- Bilyeu, 2002, Interspecies comparison: In vitro metabolism of J867 by hepatocytes and microsomes from male and female human, and various animal species., Drug Metab Rev, 34, 46
- Morris, 2002, Interspecies comparison of the metabolism of J867 following intravenous or oral administration to male and female bile duct-cannulated rats and mice., Drug Metab Rev, 34, 73
Cited by
Items 201–300 of 315
Synthesis and biological evaluation of 11′ imidazolyl antiprogestins and mesoprogestins
Nickisch, K. J., Elger, W. A. G., Santhamma, B., Garfield, R. E., Killeen, Z., Amelkina, O., Schneider, B., & Meister, R. (2014) · Steroids · doi:10.1016/j.steroids.2014.08.017 · Cited by 8
Self-citationNew Treatments for Uterine Fibroids
Siskin, G. P. (2006) · Techniques in vascular and interventional radiology · doi:10.1053/j.tvir.2006.08.004 · Cited by 8
Next step in the development of mesoprogestins: the preclinical profile of EC313
Błaszczak-Świątkiewicz, K., Krupa, A., Mnich, E., Elger, W. A. G., Oettel, M., Nair, H. B. B., Wierzbicki, M., Sieroszewski, P., & Shaked, Z. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1201547 · Cited by 7
Self-citationMedical treatments of endometriosis: a review
Elbasueny, B., Geerts, M., Yang, E. C., Allaire, C., Yong, P. J., & Bedaiwy, M. A. (2022) · Reproductive and Developmental Medicine · doi:10.1097/rd9.0000000000000053 · Cited by 12
Operation, hormone therapy and recovery of the patients with severe forms of adenomyosis
Tskhay, V. B., Schindler, A. E., & Mikailly, G. T. (2018) · Gynecological Endocrinology · doi:10.1080/09513590.2017.1397116 · Cited by 7
Intérêt actuel des selective progesterone receptor modulators (SPRM) dans l’endométriose
Merviel, P., Lourdel, E., Sanguin, S., Gagneur, O., Cabry, R., & Nasreddine, A. (2013) · Gynécologie Obstétrique & Fertilité · doi:10.1016/j.gyobfe.2013.07.016 · Cited by 7
Spitz, I. M. (2007) · Expert Review of Obstetrics & Gynecology · doi:10.1586/17474108.2.2.227 · Cited by 7
Khan, Z., & Stewart, E. A. (2019) · Elsevier eBooks · doi:10.1016/b978-0-323-47912-7.00026-3 · Cited by 7
Anti-hormone Therapy: Principles of Endocrine Therapy of Cancer
Hoffmann, J., & Sommer, A. (2006) · Topics in medicinal chemistry · doi:10.1007/7355_2006_002 · Cited by 7
Chronic Pelvic Pain in the Adolescent
Hicks, C. W., & Rome, E. S. (2012) · Endocrine development · doi:10.1159/000326696 · Cited by 6
Expulsion of a uterine myoma in a patient treated with ulipristal acetate
Chantraine, F., Poismans, G., Nwachuku, J., Bestel, E., & Nisolle, M. (2015) · Clinical Case Reports · doi:10.1002/ccr3.211 · Cited by 6
Docking, Screening and Selectivity Prediction for Small-molecule Nuclear Receptor Modulators
Abagyan, R. A., Chen, W., & Kufareva, I. (2012) · Royal Society of Chemistry eBooks · doi:10.1039/9781849735353-00084 · Cited by 8
Application of ulipristal acetate in female patients with uterine fibroids.
Grzechocińska, B., Gadomska, H., Zyguła, A., & Wielgoś, M. (2014) · PubMed · Cited by 6
Long-term use of progestogens – getting the balance right: Molecular biology and the endometrium
Druckmann, R. A. (2007) · Gynecological Endocrinology · doi:10.1080/09513590701585045 · Cited by 6
Chronic Abdominal Pain of Gynecologic Causes: Diagnosis and Treatment
Yamamoto, M. P., Carillo, J. F., & Howard, F. M. (2014) · Springer eBooks · doi:10.1007/978-1-4939-1992-5_10 · Cited by 5
Aninye, I. O., Berg, K. C., Mollo, A. R., Nordeen, S. K., Wilson, E. M., & Shapiro, D. J. (2012) · Steroids · doi:10.1016/j.steroids.2012.02.003 · Cited by 5
AN EMERGING PRINCIPLE: SELECTIVE NUCLEAR RECEPTOR MODULATORS
Fan, P., & Jordan, V. C. (2013) · IMPERIAL COLLEGE PRESS eBooks · doi:10.1142/9781848169586_0016 · Cited by 5
Genetics and Genomics of Endometriosis
Giudice, L. C., Burney, R. O., Becker, C. M., Missmer, S. A., Montgomery, G. W., Rahmioğlu, N., Rogers, P. A. W., & Zondervan, K. T. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-813570-9.00018-8 · Cited by 8
Progesteron receptor expression in insulin producing cells of neuroendocrine neoplasms
Tachibana, T., Kasajima, A., Aoki, T., Tabata, T., McNamara, K. M., Yazdani, S., Sato, S., Fujishima, F., Motoi, F., Unno, M., et al. (2020) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2020.105694 · Cited by 5
Progestogens: effects on clinical and biochemical parameters in postmenopausal women
Archer, D. F. (2005) · Menopause The Journal of The North American Menopause Society · doi:10.1097/01.gme.0000177319.31629.52 · Cited by 5
Prolonged interval before conception following aglepristone-induced abortion in albino rats
Oguejiofor, C. F., & Ochiogu, L. S. (2013) · Animal Reproduction · Cited by 5
Current Treatment Options and Emerging Strategies for Fibroid Management
(2008) · The Internet Journal of Gynecology and Obstetrics · doi:10.5580/e81 · Cited by 4
Khan, Z., & Stewart, E. A. (2013) · Elsevier eBooks · doi:10.1016/b978-1-4557-2758-2.00027-5 · Cited by 6
Contraceptives with novel benefits
Su, Y., Lian, Q., & Ge, R. (2011) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.2012.642368 · Cited by 5
Endogenous Steroid Hormone Concentrations and Risk of Endometriosis in Nurses’ Health Study II
Shafrir, A. L., Mu, F., Eliassen, A. H., Kulkarni, M. T., Terry, K. L., Hankinson, S. E., & Missmer, S. A. (2022) · American Journal of Epidemiology · doi:10.1093/aje/kwac219 · Cited by 5
New Generation of Meso and Antiprogestins (SPRMs) into the Osteoporosis Approach
Woźniczka, M., & Błaszczak-Świątkiewicz, K. (2021) · Molecules · doi:10.3390/molecules26216491 · Cited by 4
New Insight into Progesterone-dependent Signalization
Kociszewska, K., & Czekaj, P. (2017) · Open Pharmaceutical Sciences Journal · doi:10.2174/1874844901704010011 · Cited by 3
Prise en charge des léiomyomes utérins
Vilos, G. A., Allaire, C., Laberge, P. Y., & Leyland, N. A. (2016) · Journal of Obstetrics and Gynaecology Canada · doi:10.1016/j.jogc.2016.09.063 · Cited by 3
Meta-Study of the Clinical Effect of Conservative Treatment in Uterine Fibroids
Zhu, H., Lai, X., Wu, J., Guan, C., & Yu, J.-H. (2022) · Journal of Oncology · doi:10.1155/2022/6114287 · Cited by 3
RetractedDiscontinued drug in 2007: renal, endocrine and metabolic drugs
Colca, J. R. (2008) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.17.11.1641 · Cited by 3
Nair, H. B. B., Santhamma, B., Krishnegowda, N. K., Dileep, K. V., & Nickisch, K. J. (2016) · PLoS ONE · doi:10.1371/journal.pone.0151182 · Cited by 3
Pourcelot, A.-G., Capmas, P., & Fernandez, H. (2017) · Journal of Gynecology Obstetrics and Human Reproduction · doi:10.1016/j.jogoh.2017.02.001 · Cited by 3
Rabe, T., Hj, A., Albring, C., Bitzer, J., Bouchard, P., Cirkel, U., Egarter, C., König, K., Harlfinger, W., Matzko, M., et al. (2013) · Journal für Kardiologie (Krause & Pachernegg GmbH) · Cited by 3
Uterine myoma: new and perspective options for medicinal treatment
Карева, Е. Н., & Samoylova, T. E. (2020) · Meditsinskiy sovet = Medical Council · doi:10.21518/2079-701x-2020-3-49-58 · Cited by 2
Taylor, H. S., Dong, L., Haikonen, J., Oppelt, P., Tamussino, K. F., Wenzl, R. J., Faustmann, T. A., Groettrup‐Wolfers, E., Ren, X., & Seitz, C. (2024) · F&S Reports · doi:10.1016/j.xfre.2024.03.002 · Cited by 5
A review of progesterone roles in implantation
(2024) · Journal of Sustainable Veterinary and Allied Sciences · doi:10.54328/covm.josvas.2024.183 · Cited by 2
Matrix Metalloproteinases as Biomarkers of Endometriosis and the Role of Progesterone Receptors
Singh, B. (2019) · Biomedical Journal of Scientific & Technical Research · doi:10.26717/bjstr.2019.21.003636 · Cited by 2
Oguejiofor, C. F., Ochiogu, I. S., & Uchendu, C. N. (2013) · Hrčak Portal of scientific journals of Croatia (University Computing Centre) · Cited by 2
Sex Hormone and Neuroendocrine Aspects of the Metabolic Syndrome
Nawata, H., Watanabe, T., Yanase, T., Nomura, M., Ashida, K., Min, L., & Fan, W. (2010) · Progress in brain research · doi:10.1016/s0079-6123(10)82007-2 · Cited by 2
Endometriosis: Current and Emerging Therapies
Hansen, K. A., & Eyster, K. M. (2011) · Clinical Medicine Reviews in Women s Health · doi:10.4137/cmrwh.s3269 · Cited by 2
Asoprisnil: A selective progesterone receptor modulator
Girish, C., Jayanthi, M., & Sivaraman, G. (2005) · Indian Journal of Pharmacology · doi:10.4103/0253-7613.16581 · Cited by 2
Prise en charge des léiomyomes utérins
Vilos, G. A., Allaire, C., Laberge, P. Y., Leyland, N. A., Vilos, A. G., Murji, A., & Chen, I. (2015) · Journal of Obstetrics and Gynaecology Canada · doi:10.1016/s1701-2163(15)30339-x · Cited by 2
Gupta, S., Harlev, A., Agarwal, A. K., Rakhit, M., Ellis-Kahana, J., & Parikh, S. (2015) · SpringerBriefs in reproductive biology · doi:10.1007/978-3-319-18308-4_10 · Cited by 2
Genetics and genomics of endometriosis☆
Giudice, L. C., Burney, R. O., Becker, C. M., Missmer, S. A., Montgomery, G. W., Rahmioğlu, N., Rogers, P. A. W., & Zondervan, K. T. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-91380-5.00018-6 · Cited by 3
Radiopaque bioactive microspheres as injectable biomaterials
Saralidze, K. (2008) · Research Publications (Maastricht University) · doi:10.26481/dis.20080214ks · Cited by 1
Medical Management of Women with Symptomatic Uterine Fibroids
Chwalisż, K., & Winkel, C. A. (2013) · doi:10.1002/9781118456996.ch6 · Cited by 2
Self-citationProgesterone Receptor Modulators: Current Applications and Perspectives
Bouchard, P., Kolańska, K., Daraï, É., Chabbert‐Buffet, N., & Pintiaux, A. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.64953-x · Cited by 2
Purnamasari, H. Y., Rahmasari, R., Gusmira, A., Sitorus, F. L. A. M., Mun’im, A., Elya, B., Setiawan, H., & Khayrani, A. C. (2026) · Reproductive Biology · doi:10.1016/j.repbio.2026.101210 · Cited by 1
Pharmacodynamic Evaluation: Endocrinology
Sandow, J. (2010) · Springer eBooks · doi:10.1007/978-3-540-89891-7_35 · Cited by 2
Pullen, N. (2012) · InTech eBooks · doi:10.5772/29021 · Cited by 1
Acetato de ulipristal 5 mg en el manejo de los miomas uterinos
Vázquez, F., Baró, F., Palacios, S., Parrilla, J. J., Carmona, F., Barri, P. N., Pellicer, A., Machado, F., Gilabert–Estellés, J., Martínez, F., et al. (2012) · Progresos de Obstetricia y Ginecología · doi:10.1016/s0304-5013(12)73067-4 · Cited by 1
Medical Management of leipmyomas-emphasis for different geographical regions
KocharKaur, K. (2015) · Journal of Gynecology & Neonatal Biology · doi:10.15436/2380-5595.15.010 · Cited by 1
Endometrial effects of selectiveprogesterone receptor modulators
Chwalisż, K., Williams, A. R. W., & Brenner, R. (2008) · Reproductive medicine and assisted reproductive techniques series · doi:10.3109/9780203091500.040 · Cited by 1
Endometriosis diagnosis and medical treatment: Present and future
Núñez-Troconis, J. (2021) · Gaceta Médica de Caracas · doi:10.47307/gmc.2021.129.2.12 · Cited by 2
Selective progesterone receptor modulators for the treatment of dysmenorrhea: an update
Speciale, A. R., Özpınar, K., Giani, M., Türeli, D., Fambrini, M., Vannuccini, S., & Petraglia, F. (2025) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2025.2451145 · Cited by 1
Wu, X., Yu, Z.-H., Qiu, J., Yang, Y.-H., Shen, X., & Su, P. (2013) · Journal of Huazhong University of Science and Technology [Medical Sciences] · doi:10.1007/s11596-013-1111-1 · Cited by 1
Stewart, E. A. (2009) · Elsevier eBooks · doi:10.1016/b978-1-4160-4907-4.00025-5 · Cited by 1
Singha, L. S., & Sreenivasa Rao, T. (2021) · Asian Journal of Pharmaceutical and Clinical Research · doi:10.22159/ajpcr.2021.v14i4.40631 · Cited by 1
Menopause and Hormone Replacement Therapy
Büyük, E., & Santoro, N. F. (2010) · Elsevier eBooks · doi:10.1016/b978-0-08-046884-6.01133-7 · Cited by 1
Medikamentöse Therapie der Endometriose
Schäfer, S. D. (2013) · Der Gynäkologe · doi:10.1007/s00129-013-3218-7 · Cited by 1
Endometriosis and ovarian reserve : Inflammation and prognostic markers
Falconer, H. (2008) · Figshare · Cited by 1
Ersoy, B. (2015) · The Sydney eScholarship Repository (The University of Sydney) · Cited by 1
Menopause and Hormone Replacement Therapy
Santoro, N. F., & Chervenak, J. L. (2004) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2004.08.001 · Cited by 1
Opportunities for development of novel therapies targeting steroid hormone receptors
Bai, C., Flores, O. A., & Schmidt, A. (2007) · Expert Opinion on Drug Discovery · doi:10.1517/17460441.2.5.725 · Cited by 1
Progesterone Receptor Isoforms : functional Selectivity and Pharmacological Targeting
Khan, J. A. (2011) · theses.fr (ABES) · doi:10.70675/d565fcfezaed8z42f4za43az5b89ba52f3ae · Cited by 1
Medikamentöse Therapie der chronischen Endometriose
Schäfer, S. D., & Kiesel, L. (2011) · Gynäkologische Endokrinologie · doi:10.1007/s10304-011-0441-y
Suárez-Calderón, D. M., & Díaz-Yamal, I. J. (2008) · Revista Colombiana de Obstetricia y Ginecología · doi:10.18597/rcog.428
SANDOW, J. (2011) · Wiley eBooks · doi:10.1002/14356007.a13_089.pub2 · Cited by 1
Firnhaber, S. (2007) · DuEPublico (University of Duisburg-Essen) · Cited by 1
Gene Expression Profiling in Leiomyoma in Response to GnRH Therapy and TGF-β
Chegini, N., & Luo, X. (2007) · Humana Press eBooks · doi:10.1007/978-1-59745-309-7_4
Innovative approaches in the treatment of the uterine myoma to restore reproductive function
Bejenar, V. F., Vladimirovich, K. E., Dedul, A. G., Шевелева, Т. С., Viktorovich, M. A., Alexandrovna, K. E., Зубарева, Т. М., & Zainab, G. (2015) · Gynecological Endocrinology · doi:10.3109/09513590.2015.1085197
Hormontherapie bei gynäkologischen, nichtmalignen Erkrankungen: Endometriose, Myome
Schäfer, S. D., Braun, J. M., & Kiesel, L. (2013) · Der Gynäkologe · doi:10.1007/s00129-012-3071-0
Actualización del uso de anticonceptivos en el tratamiento de la endometriosis
Triano-Sánchez, R., & de Prado-Prieto, L. (2011) · Medicina de Familia SEMERGEN · doi:10.1016/j.semerg.2011.09.004 · Cited by 4
Modulateurs du récepteur de la progestérone
Chabbert‐Buffet, N. (2009) · EMC - Gynécologie · doi:10.1016/s0246-1064(09)44671-1
Le THS : abandon ? Le THM : avenir…
Drapier-Faure, E. (2005) · Gynécologie Obstétrique & Fertilité · doi:10.1016/j.gyobfe.2005.09.003
Chronische Endometriose: medikamentöse Therapie
Schäfer, S. D., & Kiesel, L. (2010) · Der Gynäkologe · doi:10.1007/s00129-010-2591-8
Pharmacological treatment of endometriosis: update from recent clinical trials
Ferrero, S., Remorgida, V., & Venturini, P. L. (2011) · Clinical Investigation · doi:10.4155/cli.10.4
Moduladores del receptor de la progesterona
Chabbert‐Buffet, N. (2009) · EMC - Ginecología-Obstetricia · doi:10.1016/s1283-081x(09)70779-9 · Cited by 1
Medikamentöse Therapie der Endometriose und Adenomyose
Ahrens, T. (2015) · Gynäkologische Endokrinologie · doi:10.1007/s10304-015-0042-2
Endométriose : pourquoi se développe-telle ?
Béliard, A., Foidart, J.-M., & Nisolle, M. (2012) · ORBi (University of Liège) · Cited by 1
Selektive Progesteronrezeptormodulatoren
Neulen, J. (2008) · Gynäkologische Endokrinologie · doi:10.1007/s10304-008-0267-4
Cystic degeneration of uterine leiomyoma during ulipristal acetate treatment
(2016) · Uterus & Ovary · doi:10.14800/uo.1077
Rectovaginal endometriosis : pain treatment options
Tarjanne, S. (2016) · Helda - University of Helsinki Institutional Repository
Suárez-Calderón, D. M., & Díaz-Yamal, I. J. (2008) · DOAJ (DOAJ: Directory of Open Access Journals)
Uterine sparing treatment of leiomyomas by central or peripheral occlusion of the arterial supply
Hald, K. (2010) · NORA - Norwegian Open Research Archives
Albring, C., Bitzer, J., Bouchard, P., Cirkel, U., Egarter, C., König, K., Harlfinger, W., Matzko, M., Mueck, A. O., Römer, T., et al. (2014)
Molecular Pharmacology of Estrogen and Progesterone Receptors
Sherk, A. B., & McDonnell, D. P. (2007) · Elsevier eBooks · doi:10.1016/b978-012369443-0/50004-1
Hicks, C. W., & Rome, E. S. (2011) · WORLD SCIENTIFIC eBooks · doi:10.1142/9789814324496_0006
Moduladores selectivos del receptor de la progesterona
Keller, V., Esber, N., Daraï, É., Bouchard, P., & Chabbert‐Buffet, N. (2016) · EMC - Ginecología-Obstetricia · doi:10.1016/s1283-081x(16)79133-8
Small molecule inhibitors: novel probes of progesterone receptor action
Aninye, I. O. (2012) · Illinois Digital Environment for Access to Learning and Scholarship (University of Illinois at Urbana-Champaign)
Modulateurs sélectifs du récepteur de la progestérone
Keller, V. A., Esber, N., Daraï, É., Bouchard, P., & Chabbert‐Buffet, N. (2015)
Medical Management of Symptomatic Fibroids: Worth It?
Hegde, C. V. (2017) · The Journal of Obstetrics and Gynecology of India · doi:10.1007/s13224-017-1020-5
Multiple Symptomatic Intramural Fibroids in a Patient Who Desires Fertility
Omar, M. K., Browne, P. C., Diamond, M. P., & Al-Hendy, A. A. (2017) · Springer eBooks · doi:10.1007/978-3-319-58780-6_15
Bhattacharyya, D. (2017) · Journal of Medical Science And clinical Research · doi:10.18535/jmscr/v5i11.82
Anatomic Abnormalities and Recurrent Implantation Failure
Goldberg, J. M., Gingold, J. A., & Llarena, N. C. (2017) · Springer eBooks · doi:10.1007/978-3-319-71967-2_10 · Cited by 1
Les modulateurs sélectifs du récepteur de la progestérone : applications actuelles et perspectives
Kolańska, K., Bouchard, P., Daraï, É., & Chabbert‐Buffet, N. (2019) · Elsevier eBooks · doi:10.1016/b978-2-294-75965-9.00017-9
Ulipristalacetat – aktueller Stellenwert in der Myombehandlung
Römer, T. (2019) · Gynäkologische Endokrinologie · doi:10.1007/s10304-019-00288-9
Endometriosis - Review Of Current Therapeutic Aproaches For Disease Control
Spasova, V., Karamisheva, V., Staneva, R., Hadjidekova, S. P., Antonova, O., Koleva, L., & Toncheva, D. I. (2019) · Annual for Hospital Pharmacy · doi:10.14748/ahp.v5i1.5971
Moravek, M. B., & Bulun, S. E. (2015) · Elsevier eBooks · doi:10.1016/b978-0-323-18907-1.00131-1
Vilos, G. A., Allaire, C., Laberge, P. Y., & Leyland, N. A. (2015) · Reproductive Endocrinology · doi:10.18370/2309-4117.2015.24.59-73
Metadata
- Authors
- Chwalisz, K., Perez, M. C., DeManno, D., Winkel, C., Schubert, G., & Elger, W.
- Affiliations
- TAP Pharmaceutical Products, Inc. (K.C., M.C.P., D.D.), Lake Forest, Illinois 60045;
- Georgetown University (US)
- Jenapharm GmbH & Co. (G.S.), 07745 Jena, Germany;
- EnTec GmbH (W.E.), 07745 Jena, Germany
- Venue
- Endocrine Reviews
- Publisher
- The Endocrine Society
- Published
- 2005-04-27
- Volume
- 26
- Issue
- 3
- Pages
- 423-438
- ISSN
- 0163-769X (ISSN-L)
- 1945-7189
- OpenAlex
- W1986914259
- Cited by
- 310
- References
- 127
- Citations by year
- 2026: 4 · 2025: 2 · 2024: 4 · 2023: 4 · 2022: 6 · 2021: 5 · 2020: 9 · 2019: 16 · 2018: 18 · 2017: 23 · 2016: 11 · 2015: 21 · 2014: 19 · 2013: 21 · 2012: 21
- FWCI
- 5.03
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Endocrine Reviews (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Obstetrics and Gynecology › Uterine Myomas and Treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Endocrinology › Estrogen and related hormone effects
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Reproductive Health and Contraception
- Keywords
- selective progesterone receptor modulators, asoprisnil, uterine fibroids, leiomyoma, endometriosis, amenorrhea, dysmenorrhea, drug development
- MeSH terms
- Animals, Clinical Trials as Topic, Endometriosis, Estrenes, Female, Humans, Leiomyoma, Oximes, Oxytocics, Progesterone, Receptors, Progesterone, Uterine Neoplasms
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.